Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2002-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1161/HQ0402.105901PMID 11950706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

  2001cited by this paper
• Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules

  2001cited by this paper
• Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT)

  2001cited by this paper
• High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock

  2001cited by this paper
• Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk.

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Recombinant apolipoproteins for the treatment of vascular diseases.

  1999cited by this paper
• High-density lipoprotein: multipotent effects on cells of the vasculature.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Gene targets and approaches for raising HDL.

  1999cited by this paper
• Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

  1999cited by this paper
• Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction.

  1999cited by this paper
• Intercellular adhesion molecule (ICAM-1) and the risks of developing atherosclerotic disease.

  1998cited by this paper
• Intercellular adhesion molecule (ICAM-1) and the risks of developing atherosclerotic disease.

  1998cited by this paper
• Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

  1998cited by this paper
• Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion.

  1998cited by this paper
• Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.

  1998cited by this paper
• Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins.

  1997cited by this paper
• Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.

  1997cited by this paper
• Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

  1997cited by this paper
• Elevation of soluble adhesion molecules is associated with the severity of myocardial damage in acute myocardial infarction.

  1997cited by this paper
• Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.

  1997cited by this paper
• Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content.

  1996cited by this paper
• Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.

  1996cited by this paper
• Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome.

  1996cited by this paper
• Levels of soluble cell adhesion molecules in patients with dyslipidemia.

  1996cited by this paper
• Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970's and the 1980's. The Italian RIFLE Pooling Project. Risk factors and life expectancy.

  1995cited by this paper
• High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

  1995cited by this paper
• Concentration of soluble vascular cell adhesion molecule‐1 (VCAM‐1) correlated with expression of VCAM‐1 mRNA in the human atherosclerotic aorta

  1995cited by this paper
• Drug control of reverse cholesterol transport.

  1994cited by this paper
• Cell adhesion molecules in coronary artery disease.

  1994cited by this paper
• Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis

  1994cited by this paper
• Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus.

  1994cited by this paper
• The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosis

  1993cited by this paper
• Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

  1993cited by this paper
• An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium.

  1993cited by this paper
• Circulating adhesion molecules in disease.

  1993cited by this paper
• High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.

  1993cited by this paper
• Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.

  1991cited by this paper
• High-density lipoprotein--the clinical implications of recent studies.

  1989cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

  1982cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• A sensing strategy based on novel pyrene-functionalized MOFs for sVCAM-1 detection and prognostic assessment in coronary heart disease.

  2025cites this paper
• High-Density Lipoprotein Anti-Inflammatory Capacity and Acute Kidney Injury After Cardiac and Vascular Surgery: A Prospective Observational Study

  2024cites this paper
• Correlations Between the Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Serum Lipid Fractions With Neovascular Age-Related Macular Degeneration

  2024cites this paper
• Beyond the Scale: Investigating Adiponectin, ICAM-1, and VCAM-1 as Metabolic Markers in Obese Adolescents with Metabolic Syndrome

  2023cites this paper
• Causal effects of serum lipid biomarkers on early age-related macular degeneration using Mendelian randomization

  2023cites this paper
• Effect of Low High-Density Lipoprotein Level on Endothelial Activation and Prothrombotic Processes in Coronary Artery Disease—A Pilot Study

  2022cites this paper
• Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans

  2021cites this paper
• High-Density Lipoproteins and Acute Kidney Injury.

  2020cites this paper
• High-density lipoproteins are a potential therapeutic target for age-related macular degeneration

  2020cites this paper
• rHDL modeling and the anchoring mechanism of LCAT activation

  2020cites this paper
• Serum E-selectin concentration is associated with risk of metabolic syndrome in females

  2019cites this paper
• Dyslipidemia in Ischemia/Reperfusion Injury.

  2019cites this paper
• Humoral immunity against HDL particle: a new perspective in cardiovascular diseases?

  2019cites this paper
• Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.

  2019cites this paper
• Pharmacological Intervention to Modulate HDL: What Do We Target?

  2018cites this paper
• Heritability and Genome-Wide Association Study of Plasma Cholesterol in Chinese Adult Twins

  2018cites this paper
• Investigating DHCR24 as a protector against cellular stress : more than just a cholesterol-synthesising enzyme

  2017cites this paper
• High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture

  2017cites this paper
• Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants.

  2017cites this paper
• Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency patient-oriented and epidemiological research

  2017cites this paper
• Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency[S]

  2017cites this paper
• Low HDL cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants

  2017influential citation
• Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis.

  2016cites this paper
• Vascular Medicine Surgery Evaluation of Increase in the Adhesion Molecules (Icam-1, Vcam-1) according to the Types of Atrial Fibrillation

  2016cites this paper
• ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers.

  2016cites this paper
• Efecto del licopeno y los carotenoides del tomate en marcadores inflamatorios de la aterosclerosis en pacientes de riesgo cardiovascular

  2016cites this paper
• The role of invariant Natural Killer T cells in SLE patients with atherosclerosis

  2016cites this paper
• Correlation between Inflammatory Markers and Lipid Parameters in a Tunisian Coronary Artery Disease Group

  2016cites this paper
• The impact of high intensity aerobic interval training (HIIT) and flaxseed oil on ICAM-1 gene expression in heart tissue in male Wistar rats

  2016cites this paper
• HDL and atherosclerosis: Insights from inherited HDL disorders.

  2015cites this paper
• The Effects of a Low-Carbohydrate Diet vs. a Low-Fat Diet on Novel Cardiovascular Risk Factors: A Randomized Controlled Trial

  2015cites this paper
• Is Low HDL Cholesterol a Marker or a Mediator of Cardiovascular Disease

  2015cites this paper
• Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function.

  2015cites this paper
• The association of ICAM E469K with cardiovascular characteristics of acromegaly.

  2015cites this paper
• Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation

  2015cites this paper
• sVCAM-1 concentration and carotid IMT values in patients with acute myocardial infarction--Atherosclerotic markers of the presence, progress and prognosis.

  2015cites this paper
• Investigating Changes in the Composition and the Function of High Density Lipoprotein after Roux-n-Y Bariatric Surgery

  2014influential citation
• HDL in innate and adaptive immunity.

  2014cites this paper
• Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea.

  2014cites this paper
• Association of E-Selectin Gene Polymorphism and Serum PAPP-A with Carotid Atherosclerosis in End-Stage Renal Disease

  2014cites this paper
• HDL and endothelial protection: examining evidence from HDL inherited disorders

  2013cites this paper
• Paraoxonases: ancient substrate hunters and their evolving role in ischemic heart disease.

  2013cites this paper
• Humoral response towards high density lipoprotein : a new mechanism for atherogenesis

  2013cites this paper
• Trastornos motores y funcionales del esófago

  2012cites this paper
• Pathophysiological Insights into Cardiovascular Health in Metabolic Syndrome

  2012cites this paper
• Increased Oxidant Stress and Inflammation in Patients with Chronic Schizophrenia

  2012cites this paper
• Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease

  2012cites this paper
• The Relationship Between High-Density Lipoprotein Cholesterol and Coronary Collateral Circulation in Patients With Coronary Artery Disease

  2012cites this paper
• Polymorphisms of vascular cell adhesion molecule1 (VCAM1) in polycystic ovary syndrome determined by quantitative real-time polymerase chain reaction and melting curve analysis.

  2012cites this paper
• High cholesterol diet effects on ischemia-reperfusion injury of the heart.

  2012cites this paper
• HDL functionality

  2012cites this paper
• Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial

  2012cites this paper
• Soluble intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in asymptomatic dyslipidemic subjects.

  2011cites this paper
• Insulin resistance is associated with at least threefold increased risk for prothrombotic state in severely obese youngsters

  2011cites this paper
• Low Levels of Serum Paraoxonase Activities are Characteristic of Metabolic Syndrome and May Influence the Metabolic-Syndrome-Related Risk of Coronary Artery Disease

  2011cites this paper
• Differential effects of low-carbohydrate and low-fat diets on inflammation and endothelial function in diabetes.

  2011cites this paper
• Evolving Concepts of the Role of High-Density Lipoprotein in Protection from Atherosclerosis

  2011cites this paper
• High-Oleic Ground Beef, Exercise, and Risk Factors for Cardiovascular Disease in Men and Postmenopausal Women

  2010cites this paper
• Intake of the plant lignans matairesinol, secoisolariciresinol, pinoresinol, and lariciresinol in relation to vascular inflammation and endothelial dysfunction in middle age-elderly men and post-menopausal women living in Northern Italy.

  2010cites this paper
• Interrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammation.

  2010cites this paper
• Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology?

  2010cites this paper
• Molecular mechanism of the anti-inflammatory effect of fenofibrate

  2010cites this paper
• Efecto de la ingesta de una sobrecarga de glucosa sobre los marcadores sericos de adhesion en mujeres obesas

  2009cites this paper
• Anti-inflammatory effects of fibrates: an overview.

  2009cites this paper
• [Effect of a high glucose load on serum adhesion markers in obese women].

  2009cites this paper
• Polymorphisms cyclooxygenase-2 -765G>C and interleukin-6 -174G>C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts.

  2009cites this paper
• Influence of vitamin E supplementation on endothelial complications in type 2 diabetes mellitus patients who underwent coronary artery bypass graft.

  2009cites this paper
• A Novel ELISA to Detect Methionine Sulfoxide−Containing Apolipoprotein A−I

  2009cites this paper
• Adiposity is Associated with Endothelial Activation in Healthy 2-3 Year-old Children

  2009cites this paper
• The paraoxonases: role in human diseases and methodological difficulties in measurement

  2009cites this paper
• A meal rich in oleic acid beneficially modulates postprandial sICAM-1 and sVCAM-1 in normotensive and hypertensive hypertriglyceridemic subjects.

  2008cites this paper
• Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

  2008cites this paper
• Obesità viscerale e dislipidemia: meccanismi fisiopatologici, implicazioni cliniche e terapia

  2008cites this paper
• High-density lipoprotein subclasses distribution and composition in Mexican adolescents with low HDL cholesterol and/or high triglyceride concentrations, and its association with insulin and C-reactive protein.

  2008cites this paper
• Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects.

  2008cites this paper
• The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

  2008cites this paper
• High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus

  2008cites this paper
• Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.

  2008cites this paper
• The Peroxisome Proliferator-Activated Receptor- (cid:1) Agonist Pioglitazone Represses Inflammation in a Peroxisome Proliferator-Activated Receptor- (cid:2) – Dependent Manner In Vitro and In Vivo in Mice

  2008cites this paper
• Étude des mécanismes athérogènes associés à l'insulino-résistance et l'hypercholestérolémie familiale

  2008cites this paper
• Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.

  2008cites this paper
• HDL-cholesterol modulation and its impact on the management of cardiovascular risk

  2008cites this paper
• Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.

  2008cites this paper
• New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease

  2007cites this paper
• [Inflammatory biomarkers: the link between obesity and associated pathologies].

  2007cites this paper
• PPARalpha in atherosclerosis and inflammation.

  2007cites this paper
• Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children.

  2007cites this paper
• PPARα in atherosclerosis and inflammation

  2007cites this paper
• High-density lipoprotein cholesterol and residual cardiometabolic risk in metabolic syndrome.

  2007cites this paper
• Normal Vascular Function Despite Low Levels of High-Density Lipoprotein Cholesterol in Carriers of the Apolipoprotein A-IMilano Mutant

  2007cites this paper
• Evaluation of C-Reactive Protein, Endothelin-1, Adhesion Molecule(s), and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus Patients

  2007cites this paper
• Dietary patterns and markers of systemic inflammation among Iranian women.

  2007cites this paper
• High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease

  2006cites this paper
• LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and others.

  2006cites this paper
• Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–&agr; Activators: Clinical and Experimental Evidence

  2006cites this paper
• Circulating markers of endothelial function in cardiovascular disease.

  2006cites this paper
• Metabolic syndrome aggravates the increased endothelial activation and low‐grade inflammation in subjects with familial low HDL

  2006influential citation
• The antiatherogenic and antiinflammatory effect of HDL–associated lysosphingolipids operates via Akt ➞NF–kappaB signalling pathways in human vascular endothelial cells

  2006cites this paper
• Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury.

  2006cites this paper
• Lipids and the endothelium: an update

  2006cites this paper